Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease.

Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T.

Biol Blood Marrow Transplant. 2013 Oct;19(10):1525-9. doi: 10.1016/j.bbmt.2013.07.027. Epub 2013 Aug 6.

2.

Decreased secretion of Paneth cell α-defensins in graft-versus-host disease.

Eriguchi Y, Nakamura K, Hashimoto D, Shimoda S, Shimono N, Akashi K, Ayabe T, Teshima T.

Transpl Infect Dis. 2015 Oct;17(5):702-6. doi: 10.1111/tid.12423. Epub 2015 Sep 26.

PMID:
26198302
3.

Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.

Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, Atkinson K, Hart DN, Munster DJ, Rice AM.

Transplantation. 2008 Oct 15;86(7):968-76. doi: 10.1097/TP.0b013e3181874787.

PMID:
18852664
5.

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

Strober S.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. Epub 2007 Sep 10. Review.

PMID:
17827036
7.

Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Hossain MS, Jaye DL, Pollack BP, Farris AB, Tselanyane ML, David E, Roback JD, Gewirtz AT, Waller EK.

J Immunol. 2011 Nov 15;187(10):5130-40. doi: 10.4049/jimmunol.1101334. Epub 2011 Oct 17.

8.

Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.

Ikegame K, Yoshihara S, Taniguchi Y, Kaida K, Inoue T, Okada M, Taniguchi K, Hasei H, Tamaki H, Fujioka T, Kato R, Soma T, Ogawa H.

Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27.

PMID:
21689724
9.

Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.

Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, Shimoda S, Iwasaki H, Shimono N, Ayabe T, Akashi K, Teshima T.

Blood. 2012 Jul 5;120(1):223-31. doi: 10.1182/blood-2011-12-401166. Epub 2012 Apr 24. Erratum in: Blood. 2014 Aug 14;124(7):1201.

10.
11.

Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Avanzini MA, Maccario R, Locatelli F, Giebel S, Santos CD, Bernardo ME, Pagliara D, Montagna D, Longo S, Amendola G, Marconi M.

Exp Hematol. 2006 Oct;34(10):1429-34.

PMID:
16982336
12.

The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation.

Fändrich F, Zepernick-Kalinski C, Gebhardt H, Henne-Bruns D, Zavazava N, Lin X.

Transpl Immunol. 1999 Mar;7(1):1-7.

PMID:
10375071
13.
14.

Graft-versus-host disease in mini-transplant.

Mineishi S, Schuening FG.

Leuk Lymphoma. 2004 Oct;45(10):1969-80. Review.

PMID:
15370240
15.

Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.

Yamasaki S, Miyagi-Maeshima A, Kakugawa Y, Matsuno Y, Ohara-Waki F, Fuji S, Morita-Hoshi Y, Mori M, Kim SW, Mori S, Fukuda T, Tanosaki R, Shimoda T, Tobinai K, Saito D, Takaue Y, Teshima T, Heike Y.

Int J Hematol. 2013 Mar;97(3):421-6. doi: 10.1007/s12185-013-1297-9. Epub 2013 Feb 23.

PMID:
23435651
16.
17.

Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.

Welniak LA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ.

Biol Blood Marrow Transplant. 2000;6(6):604-12.

18.

Towards a rational graft-versus-host disease (GVHD) prophylaxis: rituximab should not be forgotten.

Van Hoef ME.

Haematologica. 2013 Apr;98(4):e40-1. doi: 10.3324/haematol.2012.082271. No abstract available.

19.

Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.

Liu D, Yan C, Xu L, Wang Y, Han W, Zhang X, Liu K, Huang X.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1567-75. doi: 10.1016/j.bbmt.2010.05.001. Epub 2010 Sep 15.

20.

[Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice].

Wang SB, Guo KY, Hu DM, Yin B.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jun;26(6):810-3. Chinese.

Supplemental Content

Support Center